(Q36055764)

11 August 2017

1 reference

title

Optimised glucocorticoid therapy: the sharpening of an old spear (English)

1 reference

11 August 2017

author

Gerd-Rüdiger Burmester

series ordinal

2

object named as

Gerd-Rüdiger Burmester

0 references

Frank Buttgereit

series ordinal

1

object named as

Frank Buttgereit

0 references

author name string

Brian J Lipworth

series ordinal

3

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 February 2005

1 reference

11 August 2017

number of pages

3

1 reference

inferred from page(s)

published in

The Lancet

1 reference

11 August 2017

volume

365

1 reference

11 August 2017

issue

9461

1 reference

11 August 2017

page(s)

801-803

1 reference

Mechanisms involved in the side effects of glucocorticoids

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917989-6

7 January 2021

Glucocorticoids in the treatment of rheumatic diseases: an update on the mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917989-6

7 January 2021

Anniversary: 50 years of glucocorticoid treatment in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917989-6

7 January 2021

Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917989-6

7 January 2021

Long-term, high-dose glucocorticoids and bone mineral content in childhood glucocorticoid-sensitive nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917989-6

7 January 2021

Bare-bones fact--children are not small adults

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917989-6

7 January 2021

Liposomes for scintigraphic detection of infection and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917989-6

7 January 2021

Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917989-6

7 January 2021

Drug targeting by long-circulating liposomal glucocorticosteroids increases therapeutic efficacy in a model of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917989-6

7 January 2021

Generation of innovative anti-inflammatory and anti-arthritic glucocorticoid derivatives that release NO: the nitro-steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917989-6

7 January 2021

Biphasic regulation of NF-kappa B activity underlies the pro- and anti-inflammatory actions of nitric oxide.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917989-6

7 January 2021

21-NO-prednisolone is a novel nitric oxide-releasing derivative of prednisolone with enhanced anti-inflammatory properties

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917989-6

7 January 2021

Potent antiarthritic properties of a glucocorticoid derivative, NCX-1015, in an experimental model of arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917989-6

7 January 2021

Glucocorticoid receptor nitration leads to enhanced anti-inflammatory effects of novel steroid ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917989-6

7 January 2021

Hepatic nuclear factor 3- and hormone-regulated expression of the phosphoenolpyruvate carboxykinase and insulin-like growth factor-binding protein 1 genes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917989-6

7 January 2021

Dissociation of transactivation from transrepression by a selective glucocorticoid receptor agonist leads to separation of therapeutic effects from side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917989-6

7 January 2021

trans-Activation and repression properties of the novel nonsteroid glucocorticoid receptor ligand 2,5-dihydro-9-hydroxy-10-methoxy-2,2,4-trimethyl-5-(1-methylcyclohexen-3-y1)-1H-[1]benzopyrano[3,4-f]quinoline (A276575) and its four stereoisomers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917989-6

7 January 2021

Designer glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917989-6

7 January 2021

A novel antiinflammatory maintains glucocorticoid efficacy with reduced side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2917989-6

7 January 2021

10.1016/S0140-6736(05)17989-6

Identifiers

DOI

1 reference

11 August 2017

1 reference